TR200001646T2 - Bir salgılanmış meme kanseri proteini olan mamaglobin. - Google Patents

Bir salgılanmış meme kanseri proteini olan mamaglobin.

Info

Publication number
TR200001646T2
TR200001646T2 TR2000/01646T TR200001646T TR200001646T2 TR 200001646 T2 TR200001646 T2 TR 200001646T2 TR 2000/01646 T TR2000/01646 T TR 2000/01646T TR 200001646 T TR200001646 T TR 200001646T TR 200001646 T2 TR200001646 T2 TR 200001646T2
Authority
TR
Turkey
Prior art keywords
mammaglobin
breast cancer
mamaglobin
cancer protein
methods
Prior art date
Application number
TR2000/01646T
Other languages
English (en)
Inventor
A. Watson Mark
P. Fleming T�Mothy
Original Assignee
Washington University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University filed Critical Washington University
Publication of TR200001646T2 publication Critical patent/TR200001646T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

Bir saflastirilmis ve izole edilmis DNA dizisi ve kodlanmis memeye özgü salgilanmis protein olan mamaglobin anlatilmistir.Ayni zamanda,gögüs kanseri hücreleri tarafindan mamaglobinin salgilamasi ve fazla sentezlenmesine dayali gögüs kanserinin bulgulanmasi için yöntemlerde anlatilmistir. Yöntemler mamaglobin ya da mamaglobini kodlayan mRNA'nin mevcudiyetini bulgulamakta ve/veya nicellestirmektedir. Bir mamaglobin sentezleyen tümöre sahip bir gögüs kanserli hastanin tedavi edilmesi için imünoterapi esasli yöntemler de anlatilmis. Yöntemler, tümöre karsi bir humoral ve/veya hücre-aracili bagisiklik karsiliginin uyarilmasi için mamaglobin antigenlerinin kullanimini kapsamaktadir.
TR2000/01646T 1997-09-18 1998-09-18 Bir salgılanmış meme kanseri proteini olan mamaglobin. TR200001646T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/933,149 US5922836A (en) 1995-05-31 1997-09-18 Mammaglobin antigens

Publications (1)

Publication Number Publication Date
TR200001646T2 true TR200001646T2 (tr) 2000-10-23

Family

ID=25463453

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/01646T TR200001646T2 (tr) 1997-09-18 1998-09-18 Bir salgılanmış meme kanseri proteini olan mamaglobin.
TR2000/03685T TR200003685T1 (tr) 1997-09-18 1998-09-18 Bir salgılanmış meme kanseri proteini olan mamaglobin

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2000/03685T TR200003685T1 (tr) 1997-09-18 1998-09-18 Bir salgılanmış meme kanseri proteini olan mamaglobin

Country Status (16)

Country Link
US (1) US5922836A (tr)
EP (1) EP1037901A4 (tr)
JP (1) JP2001516569A (tr)
KR (1) KR20010030617A (tr)
CN (1) CN1277614A (tr)
AU (1) AU735338B2 (tr)
BR (1) BR9812472A (tr)
CA (1) CA2304167A1 (tr)
HU (1) HUP0004022A2 (tr)
IL (1) IL134998A0 (tr)
NO (1) NO20001358L (tr)
NZ (1) NZ503729A (tr)
PL (1) PL340689A1 (tr)
TR (2) TR200001646T2 (tr)
WO (1) WO1999014230A1 (tr)
ZA (1) ZA988526B (tr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2971700A (en) * 1999-01-21 2000-08-07 Wayne State University Method and apparatus for measuring factors in mammary fluids
AU4469400A (en) * 1999-04-20 2000-11-02 Zymogenetics Inc. Zalpha13: a human secreted protein
CA2375049A1 (en) * 1999-05-28 2000-12-07 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
AU5638400A (en) * 1999-06-23 2001-01-09 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2001040269A2 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6489101B1 (en) 1999-11-30 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2001236911A1 (en) * 2000-02-11 2001-08-20 Corixa Corporation Lipophilin complexes for use in cancer diagnosis and therapy
WO2001075171A2 (en) * 2000-04-03 2001-10-11 Corixa Corporation Methods, compositions and kits for the detection and monitoring of breast cancer
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
EP2139993A2 (en) * 2007-04-27 2010-01-06 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
KR101603400B1 (ko) * 2014-02-04 2016-03-14 경상대학교산학협력단 맘마글로빈을 포함하는 암전이 억제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US573916A (en) * 1896-12-29 Threshing-machine
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) * 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast

Also Published As

Publication number Publication date
CN1277614A (zh) 2000-12-20
TR200003685T1 (tr) 2001-04-20
IL134998A0 (en) 2001-05-20
ZA988526B (en) 1999-08-16
US5922836A (en) 1999-07-13
PL340689A1 (en) 2001-02-26
BR9812472A (pt) 2000-09-19
HUP0004022A2 (en) 2001-03-28
EP1037901A4 (en) 2003-07-16
AU9373798A (en) 1999-04-05
NO20001358D0 (no) 2000-03-15
WO1999014230A1 (en) 1999-03-25
NO20001358L (no) 2000-05-12
CA2304167A1 (en) 1999-03-25
JP2001516569A (ja) 2001-10-02
NZ503729A (en) 2001-12-21
EP1037901A1 (en) 2000-09-27
KR20010030617A (ko) 2001-04-16
AU735338B2 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
TR199701462T1 (tr) DNA Dizisi ve bununla kodlanmis meme'ye özel gögüs kanseri proteini.
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU7697301A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
EP1064308A4 (en) METHODS FOR IDENTIFYING INDUCERS AND INHIBITORS OF PROTEOLYTIC ANTIBODIES, AND COMPOSITIONS AND USES THEREOF
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
EP1536006A4 (en) CANCER-ANIMALS AND THEIR USE
EP1054894A4 (en) BREAST CANCER RESISTANCE PROTEIN (BCRP) AND DNA CODING THIS
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
UY26170A1 (es) Antigeno (c42) asociados a tumores
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
AR023794A1 (es) Antigeno asociado con tumores
UY26127A1 (es) Antígeno asociado con tumores